Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Bartlett, John M. S.; Xu, Keying; Wong, Jenna et al.
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR plus breast cancer in the TEAM trial.JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 16. 2023
Dayan, Davut; Leinert, Elena; Singer, Susanne et al.
Association of social service counseling in breast cancer patients with financial problems, role functioning and employment-results from the prospective multicenter BRENDA II studyARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 307. H. 2. 2023 S. 541-547
Strebel, Sven; Baust, Katja; Grabow, Desiree et al.
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE studyJOURNAL OF CANCER SURVIVORSHIP. 2023
Theis, S; Hasenburg, A; Almstedt, K
Beschwerden helfen?Gynäkologische Praxis. Bd. 50. H. 1. 2023 S. 1-8
Wirth, Matthias; Brenner, Walburgis; Kraemer, Oliver H.
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseasesSIGNAL TRANSDUCTION AND TARGETED THERAPY. Bd. 8. H. 1. 2023
Hauptmann, Michael; Byrnes, Graham; Cardis, Elisabeth et al.
Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort studyLANCET ONCOLOGY. Bd. 24. H. 1. 2023 S. 45-53
Moebus, Volker; Schmidt, Marcus
Breast Cancer Outome - What have we achievedBREAST CARE. 2023
Schraw, Jeremy M.; Petridou, Eleni Th.; Bonaventure, Audrey et al.
Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International ConsortiumCANCER CAUSES & CONTROL. 2023
Ronckers, Cecile M.; Kratz, Christian P.; Gonzalez, Amy Berrington de
Cancer-predisposing germline variants and subsequent cancer riskLANCET ONCOLOGY. Bd. 24. H. 10. 2023 S. 1059-1061
Harbeck, Nadia; Fasching, Peter A.; Wuerstlein, Rachel et al.
CANKADO PRO-React eHealth support in patients with HR+HER2-metastatic breast cancer receiving palbociclib and endocrine therapy and the affect on time to deterioration of quality of life: Primary outcome analysis of the multicenter randomized PreCycle trialJOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 16. 2023